NEW YORK, May 2 (GenomeWeb News) - Invitrogen will spend £12.7 million ($23.3 million) to "consolidate" and "expand" its operations in Scotland, the Scottish Enterprise, the nation's main economic-development agency, said today.
Among the expansion is a plan to create a new global corporate research center in Inchinnan in the outskirts of
The move, which will be supported with a £4.3-million investment from
Terms of the expansion call for Invitrogen to "amalgamate" its current manufacturing and product development sites across
The base, which will be moved into a 90,000-square-foot facility, will become the firm's European headquarters, and will have additional resources for R&D, sales, finance, legal, and customer services functions.
The move will "enable the company to meet increased business demand in a more cost effective way and has the potential for future expansion," Bernd Brust, vice president and general manager of Invitrogen Europe, said in a statement.
An Invitrogen spokesperson said construction on the new facility will begin this summer, and it is slated to open in the fall of 2007. Invitrogen will finish transferring staff and operations at that time, the spokesperson added.